beta

RVLP

RVL Pharmaceuticals plc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

osmotica pharmaceutical is focused on drug delivery technologies with a special focus in neurology-based therapies. we have a portfolio of products in various stages of development focused on the treatment of movement disorders, such as ms and parkinson's disease. in addition, we utilize our well-established drug delivery technologies (including our osmodex technologies) and our expertise to develop drug candidates for partner companies.

Market Cap: 3.14 Million

Primary Exchange: NASDAQ

Website:

Shares Outstanding: 111 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.8979280626640577

Sector: Manufacturing

Industry: Medicinal and Botanical Manufacturing

Ethical Flags

Longest drawdown: 153 trading days

From: 2023-03-17 To: 2023-10-20

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud